CoChat

Enhancing Antimicrobial Peptide Activity through Modifications of Charge, Hydrophobicity, and Structure

Open access
Gagat, Przemysław, Ostrówka, Michał, Duda-Madej, Anna, Mackiewicz, Paweł · 2024 · International Journal of Molecular Sciences
Cited by 163

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Antimicrobial peptides (AMPs) are emerging as a promising alternative to traditional antibiotics due to their ability to disturb bacterial membranes and/or their intracellular processes, offering a potential solution to the growing problem of antimicrobial resistance. AMP effectiveness is governed by factors such as net charge, hydrophobicity, and the ability to form amphipathic secondary structures. When properly balanced, these characteristics enable AMPs to selectively target bacterial membranes while sparing eukaryotic cells. This review focuses on the roles of positive charge, hydrophobicity, and structure in influencing AMP activity and toxicity, and explores strategies to optimize them for enhanced therapeutic potential. We highlight the delicate balance between these properties and how various modifications, including amino acid substitutions, peptide tagging, or lipid conjugation, can either enhance or impair AMP performance. Notably, an increase in these parameters does not always yield the best results; sometimes, a slight reduction in charge, hydrophobicity, or structural stability improves the overall AMP therapeutic potential. Understanding these complex interactions is key to developing AMPs with greater antimicrobial activity and reduced toxicity, making them viable candidates in the fight against antibiotic-resistant bacteria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms251910821

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 133

  1. Mendelsohn, 2002, “Like All That Lives”: Biology, Medicine and Bacteria in the Age of Pasteur and Koch, Hist. Philos. Life Sci., 24, 3, 10.1080/03919710210001714293 · DOI
  2. Durand, 2019, Antibiotic Discovery: History, Methods and Perspectives, Int. J. Antimicrob. Agents, 53, 371, 10.1016/j.ijantimicag.2018.11.010 · DOI · Paper page
  3. Uddin, 2021, Antibiotic Resistance in Microbes: History, Mechanisms, Therapeutic Strategies and Future Prospects, J. Infect. Public Health, 14, 1750, 10.1016/j.jiph.2021.10.020 · DOI · Paper page
  4. Blair, 2015, Molecular Mechanisms of Antibiotic Resistance, Nat. Rev. Microbiol., 13, 42, 10.1038/nrmicro3380 · DOI · Paper page
  5. MacGowan, 2017, Antibiotic Resistance, Medicine, 45, 622, 10.1016/j.mpmed.2017.07.006 · DOI · Paper page
  6. Rizvanov, 2019, World Health Organization Report: Current Crisis of Antibiotic Resistance, BioNanoScience, 9, 778, 10.1007/s12668-019-00658-4 · DOI · Paper page
  7. Kwon, 2021, The Post-Antibiotic Era Is Here, Science, 373, 471, 10.1126/science.abl5997 · doi:10.1126/science.abl5997
  8. Mancuso, G., Midiri, A., Gerace, E., and Biondo, C. (2021). Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens, 10. · DOI · Paper page
  9. Shomuyiwa, 2023, Top 10 Public Health Challenges to Track in 2023: Shifting Focus beyond a Global Pandemic, Public Health Chall., 2, e86, 10.1002/puh2.86 · DOI
  10. Chen, C.-Y., Yang, K.-Y., Peng, C.-K., Sheu, C.-C., Chan, M.-C., Feng, J.-Y., Wang, S.-H., Chen, C.-M., Zheng, Z.-R., and Liang, S.-J. (2022). Clinical Outcome of Nosocomial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients: A Multicenter Retrospective Observational Study. Sci. Rep., 12. · DOI
  11. Peleg, 2010, Hospital-Acquired Infections Due to Gram-Negative Bacteria, N. Engl. J. Med., 362, 1804, 10.1056/NEJMra0904124 · DOI · Paper page
  12. Temkin, 2019, Zero or More: Methodological Challenges of Counting and Estimating Deaths Related to Antibiotic-Resistant Infections, Clin. Infect. Dis., 69, 2029, 10.1093/cid/ciz414 · DOI
  13. Cassini, 2019, Attributable Deaths and Disability-Adjusted Life-Years Caused by Infections with Antibiotic-Resistant Bacteria in the EU and the European Economic Area in 2015: A Population-Level Modelling Analysis, Lancet Infect. Dis., 19, 56, 10.1016/S1473-3099(18)30605-4 · DOI · Paper page
  14. Czaplewski, 2016, Alternatives to Antibiotics-a Pipeline Portfolio Review, Lancet Infect. Dis., 16, 239, 10.1016/S1473-3099(15)00466-1 · DOI · Paper page
  15. Magana, 2020, The Value of Antimicrobial Peptides in the Age of Resistance, Lancet Infect. Dis., 20, e216, 10.1016/S1473-3099(20)30327-3 · DOI · Paper page
  16. Ryu, 2021, Rediscovery of Antimicrobial Peptides as Therapeutic Agents, J. Microbiol., 59, 113, 10.1007/s12275-021-0649-z · DOI
  17. Hassan, M., Flanagan, T.W., Kharouf, N., Bertsch, C., Mancino, D., and Haikel, Y. (2023). Antimicrobial Proteins: Structure, Molecular Action, and Therapeutic Potential. Pharmaceutics, 15. · DOI
  18. Pirtskhalava, 2021, DBAASP v3: Database of Antimicrobial/Cytotoxic Activity and Structure of Peptides as a Resource for Development of New Therapeutics, Nucleic Acids Res., 49, D288, 10.1093/nar/gkaa991 · DOI · Paper page
  19. Ahmed, A., Siman-Tov, G., Hall, G., Bhalla, N., and Narayanan, A. (2019). Human Antimicrobial Peptides as Therapeutics for Viral Infections. Viruses, 11. · DOI · Paper page
  20. Hancock, 2016, The Immunology of Host Defence Peptides: Beyond Antimicrobial Activity, Nat. Rev. Immunol., 16, 321, 10.1038/nri.2016.29 · DOI · Paper page
  21. Mahlapuu, M., Håkansson, J., Ringstad, L., and Björn, C. (2016). Antimicrobial Peptides: An Emerging Category of Therapeutic Agents. Front. Cell. Infect. Microbiol., 6. · DOI · Paper page
  22. Silva, 2017, Antimicrobial Peptides: Role in Human Disease and Potential as Immunotherapies, Pharmacol. Ther., 178, 132, 10.1016/j.pharmthera.2017.04.002 · DOI
  23. Raffatellu, 2018, Learning from Bacterial Competition in the Host to Develop Antimicrobials, Nat. Med., 24, 1097, 10.1038/s41591-018-0145-0 · DOI
  24. Satyanarayana, T., Johri, B.N., and Das, S.K. (2019). Microbiome: A Source of Novel Bioactive Compounds and Antimicrobial Peptides. Microbial Diversity in Ecosystem Sustainability and Biotechnological Applications: Volume 1. Microbial Diversity in Normal & Extreme Environments, Springer. · DOI
  25. Travkova, 2017, The Interaction of Antimicrobial Peptides with Membranes, Adv. Colloid. Interface Sci., 247, 521, 10.1016/j.cis.2017.06.001 · DOI · Paper page
  26. Kumar, P., Kizhakkedathu, J.N., and Straus, S.K. (2018). Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo. Biomolecules, 8. · DOI · Paper page
  27. Ahmed, T.A.E., and Hammami, R. (2019). Recent Insights into Structure–Function Relationships of Antimicrobial Peptides. J. Food Biochem., 43. · DOI
  28. Abraham, 1987, Extension of the Fragment Method to Calculate Amino Acid Zwitterion and Side Chain Partition Coefficients, Proteins Struct. Funct. Bioinform., 2, 130, 10.1002/prot.340020207 · DOI · Paper page
  29. Andersson, 2016, Mechanisms and Consequences of Bacterial Resistance to Antimicrobial Peptides, Drug Resist. Updates, 26, 43, 10.1016/j.drup.2016.04.002 · DOI · Paper page
  30. Martins, 2018, Antibiotic-Resistant Bacteria Show Widespread Collateral Sensitivity to Antimicrobial Peptides, Nat. Microbiol., 3, 718, 10.1038/s41564-018-0164-0 · DOI · Paper page
  31. Spohn, 2019, Integrated Evolutionary Analysis Reveals Antimicrobial Peptides with Limited Resistance, Nat. Commun., 10, 4538, 10.1038/s41467-019-12364-6 · DOI · Paper page
  32. Le, 2017, Intracellular Targeting Mechanisms by Antimicrobial Peptides, Antimicrob. Agents Chemother., 61, e02340-16, 10.1128/AAC.02340-16 · DOI · Paper page
  33. Scocchi, 2016, Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria, Curr. Top. Med. Chem., 16, 76, 10.2174/1568026615666150703121009 · DOI · Paper page
  34. Matsuzaki, K. (2019). Clinical Application of AMPs. Antimicrobial Peptides: Basics for Clinical Application, Springer. Advances in Experimental Medicine and Biology. · doi:10.1007/978-981-13-3588-4
  35. Mahlapuu, 2020, Antimicrobial Peptides as Therapeutic Agents: Opportunities and Challenges, Crit. Rev. Biotechnol., 40, 978, 10.1080/07388551.2020.1796576 · DOI · Paper page
  36. Wang, 2019, Antimicrobial Peptides: Promising Alternatives in the Post Feeding Antibiotic Era, Med. Res. Rev., 39, 831, 10.1002/med.21542 · DOI · Paper page
  37. Li, B., Yang, N., Wang, X., Hao, Y., Mao, R., Li, Z., Wang, Z., Teng, D., and Wang, J. (2020). An Enhanced Variant Designed from DLP4 Cationic Peptide Against Staphylococcus Aureus CVCC 546. Front. Microbiol., 11. · DOI
  38. Hwang, 1998, Structure–Function Relationships of Antimicrobial Peptides, Biochem. Cell Biol., 76, 235, 10.1139/o98-026 · doi:10.1139/o98-026 · Paper page
  39. Li, 2021, The structure-mechanism relationship and mode of actions of antimicrobial peptides: A review, Trends Food Sci. Technol., 109, 103, 10.1016/j.tifs.2021.01.005 · DOI · Paper page
  40. Tan, 2021, Design, Optimization, and Nanotechnology of Antimicrobial Peptides: From Exploration to Applications, Nano Today, 39, 101229, 10.1016/j.nantod.2021.101229 · DOI · Paper page
  41. Wang, 2016, APD3: The Antimicrobial Peptide Database as a Tool for Research and Education, Nucleic Acids Res., 44, D1087, 10.1093/nar/gkv1278 · DOI · Paper page
  42. Burdukiewicz, M., Sidorczuk, K., Rafacz, D., Pietluch, F., Chilimoniuk, J., Rödiger, S., and Gagat, P. (2020). Proteomic Screening for Prediction and Design of Antimicrobial Peptides with AmpGram. Int. J. Mol. Sci., 21. · DOI · Paper page
  43. Sidorczuk, K., Gagat, P., Pietluch, F., Kała, J., Rafacz, D., Bąkała, L., Słowik, J., Kolenda, R., Rödiger, S., and Fingerhut, L.C. (2022). Benchmarks in Antimicrobial Peptide Prediction Are Biased Due to the Selection of Negative Data. Brief. Bioinform., 23. · DOI
  44. Pan, 2020, Macrel: Antimicrobial Peptide Screening in Genomes and Metagenomes, PeerJ, 8, e10555, 10.7717/peerj.10555 · DOI · Paper page
  45. Fingerhut, 2021, Ampir: An R Package for Fast Genome-Wide Prediction of Antimicrobial Peptides, Bioinformatics, 36, 5262, 10.1093/bioinformatics/btaa653 · DOI · Paper page
  46. Veltri, 2018, Deep Learning Improves Antimicrobial Peptide Recognition, Bioinformatics, 34, 2740, 10.1093/bioinformatics/bty179 · DOI · Paper page
  47. Lawrence, 2021, amPEPpy 1.0: A Portable and Accurate Antimicrobial Peptide Prediction Tool, Bioinformatics, 37, 2058, 10.1093/bioinformatics/btaa917 · DOI · Paper page
  48. Gautier, 2008, HELIQUEST: A Web Server to Screen Sequences with Specific α-Helical Properties, Bioinformatics, 24, 2101, 10.1093/bioinformatics/btn392 · DOI · Paper page
  49. Zhou, 2022, I-TASSER-MTD: A Deep-Learning-Based Platform for Multi-Domain Protein Structure and Function Prediction, Nat. Protoc., 17, 2326, 10.1038/s41596-022-00728-0 · DOI · Paper page
  50. Lamiable, 2016, PEP-FOLD3: Faster de Novo Structure Prediction for Linear Peptides in Solution and in Complex, Nucleic Acids Res., 44, W449, 10.1093/nar/gkw329 · DOI · Paper page
  51. Jones, 1999, Protein Secondary Structure Prediction Based on Position-Specific Scoring Matrices 1 1Edited by G. Von Heijne, J. Mol. Biol., 292, 195, 10.1006/jmbi.1999.3091 · DOI · Paper page
  52. Valle, 2024, PyAMPA: A High-Throughput Prediction and Optimization Tool for Antimicrobial Peptides, mSystems, 9, e01358-23, 10.1128/msystems.01358-23 · DOI
  53. Bessalle, 1992, Augmentation of the Antibacterial Activity of Magainin by Positive-Charge Chain Extension, Antimicrob. Agents Chemother., 36, 313, 10.1128/AAC.36.2.313 · doi:10.1128/aac.36.2.313
  54. Higgs, 2007, Modification of Chicken Avian β-Defensin-8 at Positively Selected Amino Acid Sites Enhances Specific Antimicrobial Activity, Immunogenetics, 59, 573, 10.1007/s00251-007-0219-5 · DOI
  55. Jiang, 2008, Effects of Net Charge and the Number of Positively Charged Residues on the Biological Activity of Amphipathic A-helical Cationic Antimicrobial Peptides, Biopolymers, 90, 369, 10.1002/bip.20911 · DOI · Paper page
  56. Yount, 2006, Advances in Antimicrobial Peptide Immunobiology, Biopolymers, 84, 435, 10.1002/bip.20543 · DOI · Paper page
  57. Frederiksen, 2020, Alternating Cationic-Hydrophobic Peptide/Peptoid Hybrids: Influence of Hydrophobicity on Antibacterial Activity and Cell Selectivity, ChemMedChem, 15, 2544, 10.1002/cmdc.202000526 · DOI
  58. Shang, 2016, The Effects of LPS on the Activity of Trp-Containing Antimicrobial Peptides against Gram-Negative Bacteria and Endotoxin Neutralization, Acta Biomater., 33, 153, 10.1016/j.actbio.2016.01.019 · DOI
  59. Yount, 2005, Immunocontinuum: Perspectives in Antimicrobial Peptide Mechanisms of Action and Resistance, Protein Pept. Lett., 12, 49, 10.2174/0929866053405959 · DOI
  60. Dennison, 2005, Are Oblique Orientated α-Helices Used by Antimicrobial Peptides for Membrane Invasion?, Protein Pept. Lett., 12, 27, 10.2174/0929866053406039 · DOI
  61. Glukhov, 2005, Basis for Selectivity of Cationic Antimicrobial Peptides for Bacterial Versus Mammalian Membranes, J. Biol. Chem., 280, 33960, 10.1074/jbc.M507042200 · DOI · Paper page
  62. Haney, 2007, Solution Structures and Model Membrane Interactions of Lactoferrampin, an Antimicrobial Peptide Derived from Bovine Lactoferrin, Biochim. Biophys. Acta (BBA) Biomembr., 1768, 2355, 10.1016/j.bbamem.2007.04.018 · DOI
  63. Sparks, 2014, Comparisons of Interfacial Phe, Tyr, and Trp Residues as Determinants of Orientation and Dynamics for GWALP Transmembrane Peptides, Biochemistry, 53, 3637, 10.1021/bi500439x · DOI
  64. Shahmiri, M., Cornell, B., and Mechler, A. (2017). Phenylalanine Residues Act as Membrane Anchors in the Antimicrobial Action of Aurein 1.2. Biointerphases, 12. · DOI
  65. Lander, 2023, Roles of Inter- and Intramolecular Tryptophan Interactions in Membrane-Active Proteins Revealed by Racemic Protein Crystallography, Commun. Chem., 6, 154, 10.1038/s42004-023-00953-y · DOI
  66. Schmidtchen, 2009, Boosting Antimicrobial Peptides by Hydrophobic Oligopeptide End Tags, J. Biol. Chem., 284, 17584, 10.1074/jbc.M109.011650 · DOI
  67. Schmidtchen, 2011, Membrane Selectivity by W-Tagging of Antimicrobial Peptides, Biochim. Biophys. Acta (BBA) Biomembr., 1808, 1081, 10.1016/j.bbamem.2010.12.020 · DOI
  68. Malmsten, M., Kasetty, G., Pasupuleti, M., Alenfall, J., and Schmidtchen, A. (2011). Highly Selective End-Tagged Antimicrobial Peptides Derived from PRELP. PLoS ONE, 6. · DOI
  69. Molhoek, 2010, Chicken Cathelicidin-2-Derived Peptides with Enhanced Immunomodulatory and Antibacterial Activities against Biological Warfare Agents, Int. J. Antimicrob. Agents, 36, 271, 10.1016/j.ijantimicag.2010.06.001 · doi:10.1016/j.ijantimicag.2010.06.001
  70. Molhoek, 2009, Identification of Chicken Cathelicidin-2 Core Elements Involved in Antibacterial and Immunomodulatory Activities, Mol. Immunol., 46, 2465, 10.1016/j.molimm.2009.05.019 · DOI
  71. Chen, L., Shen, T., Liu, Y., Zhou, J., Shi, S., Wang, Y., Zhao, Z., Yan, Z., Liao, C., and Wang, C. (2020). Enhancing the Antibacterial Activity of Antimicrobial Peptide PMAP-37(F34-R) by Cholesterol Modification. BMC Vet. Res., 16. · DOI
  72. Zhou, 2019, Antimicrobial Peptide PMAP-37 Analogs: Increasing the Positive Charge to Enhance the Antibacterial Activity of PMAP-37, J. Pept. Sci., 25, e3220, 10.1002/psc.3220 · doi:10.1002/psc.3220
  73. Liu, 2020, Effect of N-Methylated and Fatty Acid Conjugation on Analogs of Antimicrobial Peptide Anoplin, Eur. J. Pharm. Sci., 152, 105453, 10.1016/j.ejps.2020.105453 · DOI
  74. Zhong, 2020, Antimicrobial Peptides Conjugated with Fatty Acids on the Side Chain of D-Amino Acid Promises Antimicrobial Potency against Multidrug-Resistant Bacteria, Eur. J. Pharm. Sci., 141, 105123, 10.1016/j.ejps.2019.105123 · DOI
  75. Liu, 2021, Fatty Acid Modified-Antimicrobial Peptide Analogues with Potent Antimicrobial Activity and Topical Therapeutic Efficacy against Staphylococcus Hyicus, Appl. Microbiol. Biotechnol., 105, 5845, 10.1007/s00253-021-11454-0 · doi:10.1007/s00253-021-11454-0
  76. Chatterjee, 2013, N-Methylation of Peptides and Proteins: An Important Element for Modulating Biological Functions, Angew. Chem. Int. Ed., 52, 254, 10.1002/anie.201205674 · DOI · Paper page
  77. Smirnova, 2020, Indolicidin Analogs with Broad-Spectrum Antimicrobial Activity and Low Hemolytic Activity, Peptides, 132, 170356, 10.1016/j.peptides.2020.170356 · DOI
  78. Yeaman, 2003, Mechanisms of Antimicrobial Peptide Action and Resistance, Pharmacol. Rev., 55, 27, 10.1124/pr.55.1.2 · DOI · Paper page
  79. Dathe, 1999, Structural Features of Helical Antimicrobial Peptides: Their Potential to Modulate Activity on Model Membranes and Biological Cells, Biochim. Biophys. Acta (BBA) Biomembr., 1462, 71, 10.1016/S0005-2736(99)00201-1 · DOI · Paper page
  80. Dempsey, 1990, The Actions of Melittin on Membranes, Biochim. Biophys. Acta (BBA) Rev. Biomembr., 1031, 143, 10.1016/0304-4157(90)90006-X · DOI · Paper page
  81. Asthana, 2004, Dissection of Antibacterial and Toxic Activity of Melittin, J. Biol. Chem., 279, 55042, 10.1074/jbc.M408881200 · DOI · Paper page
  82. Chen, 2005, Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index, J. Biol. Chem., 280, 12316, 10.1074/jbc.M413406200 · DOI · Paper page
  83. Hawrani, 2008, Origin of Low Mammalian Cell Toxicity in a Class of Highly Active Antimicrobial Amphipathic Helical Peptides, J. Biol. Chem., 283, 18636, 10.1074/jbc.M709154200 · DOI
  84. Zhang, S.-K., Song, J., Gong, F., Li, S.-B., Chang, H.-Y., Xie, H.-M., Gao, H.-W., Tan, Y.-X., and Ji, S.-P. (2016). Design of an α-Helical Antimicrobial Peptide with Improved Cell-Selective and Potent Anti-Biofilm Activity. Sci. Rep., 6. · DOI · Paper page
  85. Srivastava, 2016, Modulation of Anti-Endotoxin Property of Temporin L by Minor Amino Acid Substitution in Identified Phenylalanine Zipper Sequence, Biochem. J., 473, 4045, 10.1042/BCJ20160713 · DOI
  86. Song, 2019, Therapeutic Potential of Trp-Rich Engineered Amphiphiles by Single Hydrophobic Amino Acid End-Tagging, ACS Appl. Mater. Interfaces, 11, 43820, 10.1021/acsami.9b12706 · DOI
  87. Li, 2013, Dissociation of Antimicrobial and Hemolytic Activities of Gramicidin S through N–Methylation Modification, ChemMedChem, 8, 1865, 10.1002/cmdc.201300232 · doi:10.1002/cmdc.201300232
  88. He, 2017, Design, Crystal Structure and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides against Multidrug Resistant Pseudomonas Aeruginosa, Chem. Sci., 8, 7464, 10.1039/C7SC01599B · DOI
  89. Mani, 2006, Membrane-Bound Dimer Structure of a β-Hairpin Antimicrobial Peptide from Rotational-Echo Double-Resonance Solid-State NMR, Biochemistry, 45, 8341, 10.1021/bi060305b · DOI
  90. Harwig, 1996, Intramolecular Disulfide Bonds Enhance the Antimicrobial and Lytic Activities of Protegrins at Physiological Sodium Chloride Concentrations, Eur. J. Biochem., 240, 352, 10.1111/j.1432-1033.1996.0352h.x · DOI
  91. Kokryakov, 1993, Protegrins: Leukocyte Antimicrobial Peptides That Combine Features of Corticostatic Defensins and Tachyplesins, FEBS Lett., 327, 231, 10.1016/0014-5793(93)80175-T · DOI · Paper page
  92. Tam, 2000, Membranolytic Selectivity of Cystine-stabilized Cyclic Protegrins, Eur. J. Biochem., 267, 3289, 10.1046/j.1432-1327.2000.01359.x · DOI
  93. Wiradharma, 2011, Synthetic Cationic Amphiphilic α-Helical Peptides as Antimicrobial Agents, Biomaterials, 32, 2204, 10.1016/j.biomaterials.2010.11.054 · DOI · Paper page
  94. Hu, 2011, Designed Antimicrobial and Antitumor Peptides with High Selectivity, Biomacromolecules, 12, 3839, 10.1021/bm201098j · DOI
  95. Chen, 2014, High Cell Selectivity and Low-Level Antibacterial Resistance of Designed Amphiphilic Peptide G(IIKK)3I-NH2, ACS Appl. Mater. Interfaces, 6, 16529, 10.1021/am504973d · DOI
  96. Ahmad, 2009, Structure–Function Study of Cathelicidin-Derived Bovine Antimicrobial Peptide BMAP-28: Design of Its Cell-Selective Analogs by Amino Acid Substitutions in the Heptad Repeat Sequences, Biochim. Biophys. Acta (BBA) Biomembr., 1788, 2411, 10.1016/j.bbamem.2009.08.021 · DOI
  97. Ahmad, 2009, Design of Nontoxic Analogues of Cathelicidin-Derived Bovine Antimicrobial Peptide BMAP-27: The Role of Leucine as Well as Phenylalanine Zipper Sequences in Determining Its Toxicity, Biochemistry, 48, 10905, 10.1021/bi9009874 · DOI
  98. Kumar, 2016, Single Amino Acid Substitutions at Specific Positions of the Heptad Repeat Sequence of Piscidin-1 Yielded Novel Analogs That Show Low Cytotoxicity and In Vitro and In Vivo Antiendotoxin Activity, Antimicrob. Agents Chemother., 60, 3687, 10.1128/AAC.02341-15 · DOI
  99. Cohen, 1990, α-Helical Coiled Coils and Bundles: How to Design an A-helical Protein, Proteins, 7, 1, 10.1002/prot.340070102 · DOI · Paper page
  100. Jelesarov, 1998, Salt Effects on Hydrophobic Interaction and Charge Screening in the Folding of a Negatively Charged Peptide to a Coiled Coil (Leucine Zipper), Biochemistry, 37, 7539, 10.1021/bi972977v · DOI
  101. Dou, 2017, Novel Design of Heptad Amphiphiles To Enhance Cell Selectivity, Salt Resistance, Antibiofilm Properties and Their Membrane-Disruptive Mechanism, J. Med. Chem., 60, 2257, 10.1021/acs.jmedchem.6b01457 · doi:10.1021/acs.jmedchem.6b01457
  102. Edwards, 2016, Contribution of Amphipathicity and Hydrophobicity to the Antimicrobial Activity and Cytotoxicity of β-Hairpin Peptides, ACS Infect. Dis., 2, 442, 10.1021/acsinfecdis.6b00045 · DOI · Paper page
  103. Shao, 2021, Cross-Strand Interaction, Central Bending, and Sequence Pattern Act as Biomodulators of Simplified β-Hairpin Antimicrobial Amphiphiles, Small, 17, 2003899, 10.1002/smll.202003899 · DOI
  104. Cardoso, M.H., Orozco, R.Q., Rezende, S.B., Rodrigues, G., Oshiro, K.G.N., Cândido, E.S., and Franco, O.L. (2020). Computer-Aided Design of Antimicrobial Peptides: Are We Generating Effective Drug Candidates?. Front. Microbiol., 10. · DOI · Paper page
  105. Agüero-Chapin, G., Galpert-Cañizares, D., Domínguez-Pérez, D., Marrero-Ponce, Y., Pérez-Machado, G., Teijeira, M., and Antunes, A. (2022). Emerging Computational Approaches for Antimicrobial Peptide Discovery. Antibiotics, 11. · DOI
  106. Zhang, H., Wang, Y., Zhu, Y., Huang, P., Gao, Q., Li, X., Chen, Z., Liu, Y., Jiang, J., and Gao, Y. Machine Learning and Genetic Algorithm-Guided Directed Evolution for the Development of Antimicrobial Peptides. J. Adv. Res., 2024. in press. · DOI
  107. Yoshida, 2018, Using Evolutionary Algorithms and Machine Learning to Explore Sequence Space for the Discovery of Antimicrobial Peptides, Chem, 4, 533, 10.1016/j.chempr.2018.01.005 · DOI · Paper page
  108. Maccari, G., Luca, M.D., Nifosí, R., Cardarelli, F., Signore, G., Boccardi, C., and Bifone, A. (2013). Antimicrobial Peptides Design by Evolutionary Multiobjective Optimization. PLoS Comput. Biol., 9. · DOI · Paper page
  109. Xu, J., Li, F., Leier, A., Xiang, D., Shen, H.-H., Marquez Lago, T.T., Li, J., Yu, D.-J., and Song, J. (2021). Comprehensive Assessment of Machine Learning-Based Methods for Predicting Antimicrobial Peptides. Brief. Bioinform., 22. · DOI · Paper page
  110. Walls, D., and Loughran, S.T. (2017). Antimicrobial Peptide Production and Purification. Protein Chromatography: Methods and Protocols, Springer.
  111. Gaglione, 2019, Cost-Effective Production of Recombinant Peptides in Escherichia coli, New Biotechnol., 51, 39, 10.1016/j.nbt.2019.02.004 · DOI
  112. Tiwari, P., Srivastava, Y., Sharma, A., and Vinayagam, R. (2023). Antimicrobial Peptides: The Production of Novel Peptide-Based Therapeutics in Plant Systems. Life, 13. · DOI
  113. Papo, 2002, The Consequence of Sequence Alteration of an Amphipathic α-Helical Antimicrobial Peptide and Its Diastereomers, J. Biol. Chem., 277, 33913, 10.1074/jbc.M204928200 · DOI · Paper page
  114. Li, Y., Liu, T., Liu, Y., Tan, Z., Ju, Y., Yang, Y., and Dong, W. (2019). Antimicrobial Activity, Membrane Interaction and Stability of the D-Amino Acid Substituted Analogs of Antimicrobial Peptide W3R6. J. Photochem. Photobiol. B Biol., 200. · doi:10.1016/j.jphotobiol.2019.111645
  115. Zai, Y., Ying, Y., Ye, Z., Zhou, M., Ma, C., Shi, Z., Chen, X., Xi, X., Chen, T., and Wang, L. (2020). Broad-Spectrum Antimicrobial Activity and Improved Stability of a D-Amino Acid Enantiomer of DMPC-10A, the Designed Derivative of Dermaseptin Truncates. Antibiotics, 9. · DOI
  116. Gentilucci, 2010, Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization, Curr. Pharm. Des., 16, 3185, 10.2174/138161210793292555 · DOI · Paper page
  117. Rozek, 2003, Structure-Based Design of an Indolicidin Peptide Analogue with Increased Protease Stability, Biochemistry, 42, 14130, 10.1021/bi035643g · DOI · Paper page
  118. Pham, 2013, Truncated and Constrained Helical Analogs of Antimicrobial Esculentin-2EM, Bioorganic Med. Chem. Lett., 23, 6717, 10.1016/j.bmcl.2013.10.031 · DOI
  119. Li, 2020, Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides, J. Med. Chem., 63, 4081, 10.1021/acs.jmedchem.9b02025 · DOI
  120. Park, 2004, Helix Stability Confers Salt Resistance upon Helical Antimicrobial Peptides *, J. Biol. Chem., 279, 13896, 10.1074/jbc.M311418200 · DOI
  121. Yu, 2011, Easy Strategy To Increase Salt Resistance of Antimicrobial Peptides, Antimicrob. Agents Chemother., 55, 4918, 10.1128/AAC.00202-11 · DOI · Paper page
  122. Hayes, 2021, Approaches for Peptide and Protein Cyclisation, Org. Biomol. Chem., 19, 3983, 10.1039/D1OB00411E · DOI
  123. Ye, 2018, Self-Assembly Dynamics and Antimicrobial Activity of All L- and D-Amino Acid Enantiomers of a Designer Peptide, Nanoscale, 11, 266, 10.1039/C8NR07334A · DOI
  124. Wang, 2023, Unnatural Amino Acids: Promising Implications for the Development of New Antimicrobial Peptides, Crit. Rev. Microbiol., 49, 231, 10.1080/1040841X.2022.2047008 · DOI
  125. Zhu, 2022, Antimicrobial Peptides, Conventional Antibiotics, and Their Synergistic Utility for the Treatment of Drug-Resistant Infections, Med. Res. Rev., 42, 1377, 10.1002/med.21879 · DOI · Paper page
  126. Kim, 2017, LL-37-Derived Short Antimicrobial Peptide KR-12-A5 and Its d-Amino Acid Substituted Analogs with Cell Selectivity, Anti-Biofilm Activity, Synergistic Effect with Conventional Antibiotics, and Anti-Inflammatory Activity, Eur. J. Med. Chem., 136, 428, 10.1016/j.ejmech.2017.05.028 · DOI
  127. Reffuveille, 2014, A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms, Antimicrob. Agents Chemother., 58, 5363, 10.1128/AAC.03163-14 · DOI · Paper page
  128. Song, 2020, A Broad-Spectrum Antibiotic Adjuvant Reverses Multidrug-Resistant Gram-Negative Pathogens, Nat. Microbiol., 5, 1040, 10.1038/s41564-020-0723-z · DOI · Paper page
  129. Zhang, 2021, Antimicrobial Peptides: Mechanism of Action, Activity and Clinical Potential, Mil. Med. Res., 8, 48
  130. Tripathi, A.K., Kumari, T., Harioudh, M.K., Yadav, P.K., Kathuria, M., Shukla, P.K., Mitra, K., and Ghosh, J.K. (2017). Identification of GXXXXG Motif in Chrysophsin-1 and Its Implication in the Design of Analogs with Cell-Selective Antimicrobial and Anti-Endotoxin Activities. Sci. Rep., 7. · DOI
  131. Tripathi, 2017, Selective Phenylalanine to Proline Substitution for Improved Antimicrobial and Anticancer Activities of Peptides Designed on Phenylalanine Heptad Repeat, Acta Biomater., 57, 170, 10.1016/j.actbio.2017.05.007 · DOI
  132. Porto, 2018, Joker: An Algorithm to Insert Patterns into Sequences for Designing Antimicrobial Peptides, Biochim. Biophys. Acta (BBA) Gen. Subj., 1862, 2043, 10.1016/j.bbagen.2018.06.011 · DOI · Paper page
  133. Porto, 2018, In Silico Optimization of a Guava Antimicrobial Peptide Enables Combinatorial Exploration for Peptide Design, Nat. Commun., 9, 1490, 10.1038/s41467-018-03746-3 · DOI · Paper page

Metadata

Authors
Gagat, P., Ostrówka, M., Duda-Madej, A., & Mackiewicz, P.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2024-10-09
Volume
25
Issue
19
Pages
10821
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4403253158
Cited by
163
References
7
FWCI
35.53
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.